Your session is about to expire
← Back to Search
Device
High Frequency SARS for Spinal Cord Injury (SARS600 Trial)
Phase < 1
Waitlist Available
Led By Dennis Bourbeau, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Suprasacral SCI
Neurologically stable
Must not have
Significant urethral trauma, erosion, or stricture
Bleeding diathesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new electrical stimulation pattern to help people with spinal cord injuries empty their bladders. The treatment uses electrical signals to relax the muscle that controls urine release. It aims to help these individuals urinate without needing additional surgeries or catheters. Electrical stimulation has been used historically to treat bladder dysfunction by causing muscle contraction and modulating central nervous system functions.
Who is the study for?
This trial is for adults with spinal cord injury who already use a SARS System to manage bladder function. They should be neurologically stable and not have any major urethral damage, active infections, open sores near the pelvis, or bleeding disorders.
What is being tested?
The study tests if stimulating sacral roots at certain frequencies can help empty the bladder without cutting nerves. Participants with an implanted device will try new stimulation patterns aimed at relaxing the sphincter to improve bladder emptying.
What are the potential side effects?
Potential side effects may include discomfort from electrical stimulation and possible irritation at the site of implantation. There might also be risks related to changes in bladder or bowel function due to altered nerve stimulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My spinal cord injury is above my lower back.
Select...
My neurological condition is stable.
Select...
My bones have stopped growing.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had major injury or narrowing of my urethra.
Select...
I have a bleeding disorder.
Select...
I am currently suffering from a severe infection.
Select...
I have open sores near my pelvis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
urethral sphincter pressure
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
The investigators will test an alternative pattern of sacral root stimulation in individuals who are already implanted with the device. Study participants will act as their own controls.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Finetech-Brindley Sacral Anterior Roots Stimulation System
2022
Completed Early Phase 1
~10
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for spinal cord injury (SCI) include various forms of electrical stimulation, such as sacral root stimulation, which is being studied for its ability to promote bladder emptying by relaxing the urethral sphincter. These treatments work by delivering electrical impulses to specific nerves, which can help modulate neural activity and improve function.
For instance, sacral root stimulation targets the nerves connected to the bladder, helping to coordinate bladder and sphincter activity, thus reducing the need for catheters. This is crucial for SCI patients as it can significantly improve their quality of life by reducing the risk of infections and enhancing bladder control.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,662 Total Patients Enrolled
Dennis Bourbeau, PhDPrincipal InvestigatorLouis Stokes VA Medical Center, Cleveland, OH
3 Previous Clinical Trials
21 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had major injury or narrowing of my urethra.I have a bleeding disorder.My spinal cord injury is above my lower back.My neurological condition is stable.My bones have stopped growing.I am currently suffering from a severe infection.I have open sores near my pelvis.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.